Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...

A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say. They credit ...

Adolescents with SCD often struggle with maintaining friendships, school performance, and participation in extracurricular ...

A Long Island hospital has successfully treated Sebastien Beauzile, a 21-year-old from Laurelton, with the groundbreaking ...

Anyone living with sickle cell anemia is a warrior, Leslie Davis-Primo will tell you. “I’ve had three children, largely ...

MOROGORO: The provision of screening services for sickle cell Disease and diabetes type one in newborns has continued to be ...

A young man from Laurelton is the first New Yorker with sickle cell disease to receive Lyfgenia, a life-changing gene therapy treatment that has wiped away the debilitating illness, The Post first ...

Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its ...

When Vijay Sankaran was an MD-PhD student at Harvard Medical School in the mid-2000s, one of his first clinical encounters ...

National Workshop on ‘Sickle Cell and Thalassemia Elimination: Best Practices and Scalable Strategies’ was successfully held ...

Aaron Scott, of Fayetteville, is the first in North Carolina to receive a new FDA-approved therapy which uses the patient's own cells to relieve the pain of sickle cell disease.